Millicent Sullivan is an American chemical engineer and the Alvin B. & Julie O. Stiles Professor of Chemical & Biomolecular Engineering and department chair at the University of Delaware. She is a Fellow of the American Institute for Medical and Biological Engineering. Her research considers the development of polymeric materials for targeted drug delivery and the mechanisms that underpin cell – drug interactions.
Sullivan completed her undergraduate studies at Princeton University. She moved to Carnegie Mellon University for her graduate research, where she focussed on chemical engineering. Sullivan was a Ruth L. Kirschstein postdoctoral fellow at the Benaroya Research Institute. [1] At Benaroya Sullivan worked alongside the biochemist Emily Helene Sage. [2]
In 2006 Sullivan joined the University of Delaware. Sullivan is interested in how therapeutics, including nucleic acid treatments and conventional pharmaceuticals, interact with abnormally behaving cells. [1] Targeted drug release offers the potential to improve the prognosis of various medical conditions. At the University of Delaware she was awarded an National Science Foundation CAREER Award that allowed her to study the interaction of cells with gene delivery systems. She makes use polymer-base biomaterials to package DNA-based therapeutics.
She was selected to attend the National Academy of Engineering Frontiers Symposium in 2010. [3] Alongside drug delivery, Sullivan looks to better understand the process of wound healing. She makes use of advanced gene therapies to help people with chronic, non-healing conditions. [4] She has published over 70 scholarly articles that have accrued over 2,000 citations. [5]
Sullivan plays the violin. [7]
Robert Samuel Langer Jr. FREng is an American biotechnologist, businessman, chemical engineer, chemist, and inventor. He is one of the twelve Institute Professors at the Massachusetts Institute of Technology.
Lipid nanoparticles (LNPs) are nanoparticles composed of lipids. They are a novel pharmaceutical drug delivery system, and a novel pharmaceutical formulation. LNPs as a drug delivery vehicle were first approved in 2018 for the siRNA drug Onpattro. LNPs became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle.
Jindřich Henry Kopeček was born in Strakonice, Czech Republic, as the son of Jan and Herta Zita (Krombholz) Kopeček. He is distinguished professor of pharmaceutical chemistry and distinguished professor of biomedical engineering at the University of Utah in Salt Lake City, Utah. Kopeček is also an honorary professor at Sichuan University in Chengdu, China. His research focuses on biorecognition of macromolecules, bioconjugate chemistry, drug delivery systems, self-assembled biomaterials, and drug-free macromolecular therapeutics.
The Network of Excellence for Functional Biomaterials (NFB) is a multidisciplinary research centre which hosts over sixty biologists, chemists, scientists, engineers and clinicians. It is based at the National University of Ireland, Galway, and is directed by Professor Abhay Pandit.
Paula Therese Hammond is a David H. Koch Professor in Engineering and the Head of the Department of Chemical Engineering at the Massachusetts Institute of Technology (MIT). She was the first woman and person of color appointed as head of the Chemical Engineering department. Her laboratory designs polymers and nanoparticles for drug delivery and energy-related applications including batteries and fuel cells.
William Mark Saltzman was named the Goizueta Foundation Professor of Biomedical and Chemical Engineering at Yale University on July 1, 2002 and became the founding chair of Yale's Department of Biomedical Engineering in 2003. Saltzman's research aims to promote new methods for drug delivery and develop new biotechnologies to combat human disease. A pioneer in the fields of biomaterials, nanobiotechnology, and tissue engineering, Saltzman has contributed to the design and implementation of a number of clinical technologies that have become essential to medical practice today. His popular course Frontiers of Biomedical Engineering is available to everyone through Open Yale Courses.
Joseph Kost is an Israeli academic, currently holder of The Abraham and Bessie Zacks Chair in Biomedical Engineering and the past Dean of the Faculty of Engineering Sciences at the Ben-Gurion University of the Negev.
Antonios Georgios Mikos is a Greek-American biomedical engineer who is the Louis Calder Professor of Bioengineering and Chemical and Biomolecular Engineering at Rice University. He specialises in biomaterials, drug delivery, and tissue engineering.
Jin Kim Montclare is a Professor of Chemical and Biomolecular Engineering at New York University. She creates novel proteins that can be used in drug delivery, tissue regeneration and as medical treatment. She is a 2019 AAAS Leshner Leadership Fellow and has been inducted to the AIMBE College of Fellows.
Theresa M. Reineke is an American chemist and Distinguished McKnight University Professor at the University of Minnesota. She designs sustainable, environmentally friendly polymer-based delivery systems for targeted therapeutics. She is the associate editor of ACS Macro Letters.
Kristi Lynn Kiick is the Blue and Gold Distinguished Professor of Materials Science and Engineering at the University of Delaware. She studies polymers, biomaterials and hydrogels for drug delivery and regenerative medicine. She is a Fellow of the American Chemical Society, the American Institute for Medical and Biological Engineering, and of the National Academy of Inventors. She served for nearly eight years as the deputy dean of the college of engineering at the University of Delaware.
Debra Auguste is an American chemical engineer and professor at Northeastern University in the department of chemical engineering. Auguste is dedicated to developing treatments for triple negative breast cancer, one of the most aggressive and fatal cancers that disproportionately affects African American women. Her lab characterizes biomarkers of triple negative breast cancer and develops novel biocompatible therapeutic technologies to target and destroy metastatic cancer cells. Auguste received the 2012 Presidential Early Career Award for Scientists and Engineers and in 2010 was named in the 50 Most Influential African-Americans in Technology. In 2020, Auguste became an Elected Fellow of the American Institute for Medical and Biological Engineering.
Thomas H. Epps, III is an American chemist and the Thomas & Kipp Gutshall Professor of Chemical & Biomolecular Engineering at the University of Delaware. He has a joint appointment in Materials Science & Engineering, and an affiliated appointment in Biomedical Engineering. He serves as the director of the Center for Research in Soft Matter & Polymers, the director of the Center for Hybrid, Active, and Responsive Materials, and the co-director of the Center for Plastics Innovations. His research considers the design, synthesis, characterization, and application of nanostructure-containing polymers related to biobased materials, drug delivery, alternative energy (batteries), nanotemplating, and composite-based personal-protective equipment. He is also the co-founder of Lignolix, which is focused on the valorization of biomass waste.
Hamid Ghandehari is an Iranian-American drug delivery research scientist, and a professor in the Departments of Pharmaceutics and Pharmaceutical Chemistry and Biomedical Engineering at the University of Utah. His research is focused in recombinant polymers for drug and gene delivery, nanotoxicology of dendritic and inorganic constructs, water-soluble polymers for targeted delivery and poly(amidoamine) dendrimers for oral delivery.
Arthi Jayaraman is an Indian-American scientist who is the Centennial Term Professor for Excellence in Research and Education at the University of Delaware. Her research considers the development of computational models to better understand polymer nanocomposites and biomaterials. Jayaraman was elected Fellow of the American Physical Society in 2020.
Linda Jean Broadbelt is an American chemical engineer who is the Sarah Rebecca Roland Professor and associate dean for research of the McCormick School of Engineering and Applied Science at Northwestern University. Her research considers kinetics modeling, polymerization and catalysis.
Mark Robert Prausnitz is an American chemical engineer, currently Regents’ Professor and J. Erskine Love, Jr. Chair in Chemical & Biomolecular Engineering at the Georgia Institute of Technology, He also serves as adjunct professor of biomedical engineering at Emory University and Adjunct Professor of Chemical & Biomolecular Engineering at the Korea Advanced Institute of Science and Technology. He is known for pioneering microneedle technology for minimally invasive drug and vaccine administration, which has found applications in transdermal, ocular, oral, and sustained release delivery systems.
Dextran drug delivery systems involve the use of the natural glucose polymer dextran in applications as a prodrug, nanoparticle, microsphere, micelle, and hydrogel drug carrier in the field of targeted and controlled drug delivery. According to several in vitro and animal research studies, dextran carriers reduce off-site toxicity and improve local drug concentration at the target tissue site. This technology has significant implications as a potential strategy for delivering therapeutics to treat cancer, cardiovascular diseases, pulmonary diseases, bone diseases, liver diseases, colonic diseases, infections, and HIV.
Kathryn Ann Whitehead is an American chemical engineer who is a professor at Carnegie Mellon University. Her research considers the development of nanomaterial-based drug delivery systems for gene therapy, oral macromolecular delivery systems, and maternal and infant therapeutics. She is an elected Fellow of the American Institute for Medical and Biological Engineering in 2021 and Fellow of the Controlled Release Society.
Tatiana Segura is an American biomedical engineer who is a professor at Duke University. Her research considers biomedical engineering solutions to promote cell growth. She was elected Fellow of the American Institute for Medical and Biological Engineering in 2017 and awarded the Acta Biomaterialia Silver Medal in 2021.
